Goat Anti-ILF2 / NF45 Antibody

$423.00

SKU Unit Size Price

Select a unit size:


SKU: EB07784
Formulation
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Unit Size
100 µg
Storage Instructions
Aliquot and store at -20°C. Minimize freezing and thawing.
Synonym / Alias Names
nuclear factor of activated T-cells, 45-kDa|interleukin enhancer binding factor 2|PRO3063|MGC8391|interleukin enhancer binding factor 2, 45kDa|NF45|ILF2
Accession ID
NP_004506.2; NP_001254738.1
Blocking Peptide
EBP07784
Immunogen
Peptide with sequence C-EKAYEKPPEKKEG, from the internal region (near the C Terminus) of the protein sequence according to NP_004506.2; NP_001254738.1.
Product Comments
This antibody is expected to recognize both reported isoforms (NP_004506.2; NP_001254738.1).
Peptide Sequence
C-EKAYEKPPEKKEG
Purification Method
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Shipping Instructions
Refrigerated
Predicted Species
Human, Mouse, Rat, Dog
Reactive Species
Human
Human Gene ID
3608
Mouse Gene ID
67781
Rat Gene ID
310612
Product Grade
ELISA Detection Limit
Antibody detection limit dilution 1:4000.
Western Blot
Approx 43kDa band observed in Human Tonsil and Thymus lysates (calculated MW of 43.1kDa according to NP_004506.2). Recommended concentration: 0.03-0.1µg/ml. This antibody has been successfully used in WB in the following papers: Ye J et al, RNA. 2017 Aug;23(8):1270-1284. PMID: 28487382. And Shamanna RA et al, Oncogene. 2013 Oct 24;32(43):5176-85 PMID: 23208500.
Application Type
Pep-ELISA, WB
Selected References
[{"pmid": 21969602, "intro": "This antibody (previous batch) has been successfully used in WB and IP on HeLa cells:", "title": "The NF90/NF45 complex participates in DNA break repair via nonhomologous end joining.", "author": "Shamanna RA, Hoque M, Lewis-Antes A, Azzam EI, Lagunoff D, Pe'ery T, Mathews MB.", "journal": "Mol Cell Biol. 2011 Dec;31(23):4832-43."}, {"pmid": 28487382, "intro": "This antibody has been successfully used in WB and IP on ESCs:", "title": "NF45 and NF90/NF110 coordinately regulate ESC pluripotency and differentiation", "author": "Ye J, Jin H, Pankov A, Song J, Blelloch R.", "journal": "RNA. 2017 Aug;23(8):1270-1284. "}, {"pmid": 23208500, "intro": "This antibody has been successfully used in WB on Human:", "title": "Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells.", "author": "Shamanna RA, Hoque M, Pe'ery T, Mathews MB.", "journal": "Oncogene. 2013 Oct 24;32(43):5176-85"}]